COR Cencora, Inc. Common Stock
Informazioni su Cencora, Inc. Common Stock Panoramica della società da Wikipedia
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Leggi di più
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Background
AmerisourceBergen was formed in 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. David Yost was CEO of Amerisource prior to the merger and remained in the position after the companies merged.
AmerisourceBergen has 26 pharmaceutical distribution centers in the US, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production capacity in the US and the UK. With the addition of World Courier, the largest specialty courier company in the world, over 150 company-owned offices around the globe were added to the company.
AmerisourceBergen operates its pharmaceutical distribution business under four primary units: AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS) and World Courier. In March 2016, pharmacy Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company.
In 2012, the firm was the largest by revenue based in Pennsylvania. The company changed its name to Cencora as of August 30, 2023 and began trading on the New York Stock Exchange under the new ticker symbol "COR". In May 2024, Cencora disclosed it had been the subject of a cyber incident in which patient information was exposed.
Products
They provide drug distribution and consulting related to medical business operations and patient services. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to health care providers throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers' compensation and specialty drug patients.
AmerisourceBergen handles about 20% of all of the pharmaceuticals sold and distributed throughout the United States and ranked 10th on the Fortune 500 list for 2020 with over $179 billion in annual revenue.
Good Neighbor Pharmacy
Good Neighbor Pharmacy is an American retailers' cooperative network of more than 3,400 independently owned and operated pharmacies. It has a business affiliation with AmerisourceBergen, which sponsors the network and owns the name "Good Neighbor Pharmacy." Good Neighbor Pharmacy is the sponsor for "ThoughtSpot," the annual trade show held in both Orlando and Las Vegas.
Acquisition history
In 2011, the company acquired IntrinsiQ for $35 million and Premier Source for an undisclosed amount. In July, Steven Collis replaced Yost as CEO of the company.
In March 2012, AmerisourceBergen agreed to acquire World Courier Group Inc, a transportation and logistics provider for the biopharmaceutical industry, for $520 million.
In January 2015, the company bought MWI Veterinary for $2.5 billion. In October, they agreed to buy PharMEDium, a compounding drug company, for $2.58 billion.
On January 3, 2018, AmerisourceBergen acquired H. D. Smith, the largest privately held national pharmaceutical wholesaler in the U.S.
On June 2, 2021, AmerisourceBergen acquired Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion, made up of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock.
On January 2, 2025, Cencora acquired 85% of Retina Consultants of America for approximately $4.4 billion.
Distribution of Remdesivir
In June 2020, the U.S. Department of Health and Human Services (HHS) announced an unusual agreement for the distribution of remdesivir, the first coronavirus drug. HHS agreed to manufacturer Gilead's wholesale acquisition price, while HHS would continue to work together with state governments and AmerisourceBergen to allocate shipments of remdesivir vials to American hospitals through the end of September 2020, and in exchange, during that time-frame American patients would be allocated over 90% of Gilead's projected remdesivir output of more than 500,000 treatment courses.
Finances
For the fiscal year 2019, AmerisourceBergen reported earnings of US$1.11 billion, with an annual revenue of US$179.58 billion. AmerisourceBergen's shares traded at over $88 per share, and its market capitalization was valued at over US$19.2 billion in September 2019.
Controversies
Opioid epidemic
AmerisourceBergen is among several distributors that have been sued by West Virginia for contributing to the opioid epidemic in the United States, by shipping inordinate amounts of pain medication into the state.
In December 2019, Michigan became the first state to sue AmerisourceBergen and three other opioid distributors as drug dealers for their role in the state's opioid crisis. The lawsuit is filed under the Michigan Drug Dealer Liability Act. AmerisourceBergen was among four companies who, because of their role in the addiction crisis, agreed to pay $260 million to two Ohio counties. In May 2020, Oklahoma Attorney General Mike Hunter sued AmerisourceBergen in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets." In January 2022, AmerisourceBergen, McKesson, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them. The deal covered the bulk of the grievances against these four companies, including 90 percent of municipal governments, 46 states, and Washington, DC. Had the states gone to court, the companies could have faced up to $95 billion in penalties. AmerisourceBergen and the three other companies did not admit wrongdoing.
Legal issues
In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks to physicians. The company had previously been found guilty of a misdemeanor charge related to the repackaging and distribution of pre-filled syringes that lacked FDA approval. In connection with this case, AmerisourceBergen agreed to pay $260 million, bringing the total settlement amount to $885 million.
As part of the civil settlement, ABC admitted that between January 2001 and January 2014, MII and OSC operated a program that created, packed and shipped millions of pre-filled syringes (PFS) to oncology practices for administration to vulnerable cancer patients (the PFS Program). At MII, an ABC subsidiary located in Alabama, the drug product was removed from the original glass vials and multiple vials of the product were pooled in untested plastic containers. Then the drug, including the overfill, was extracted and repackaged into syringes. By harvesting the overfill, ABC was able to create more doses than it bought from the original vial manufacturers and avoid opening some of the vials. ABC retained the unopened vials and sold them to other customers and to its subsidiary ABDC for resale. During the 13 years the PFS Program was in operation, MII manufactured thousands of syringes daily, and eventually over one million syringes per year. These syringes were sold throughout the United States. Approximately 57% of the patients who were injected with the PFS were Federal Health Care Program beneficiaries. The profit from the PFS Program was between $2.3 and $14.4 million annually for a total profit of at least $99.6 million.
ABC’s scheme enabled it to bill multiple health care providers for the same vial of drug, causing some of those providers to bill the Federal Health Care Programs for the same vial more than once. The scheme also enabled ABC to increase its market share by offering various product discounts, which it leveraged to obtain new customers and to keep existing customers who purchased its entire portfolio of oncology drugs. ABC excluded the entire PFS Program from its standard regulatory audit and pedigree compliance programs. AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. States countered with $45 billion.
In 2022, the United States government filed a lawsuit against AmerisourceBergen for contributing to the opioid crisis in America. The suit, which was filed by the United States Department of Justice with federal prosecutors in New Jersey, Colorado, Pennsylvania, and New York, alleged that the company distributed opioids that were later resold illegally.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
COR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
COR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
| Data ex-dividendo | Importo |
|---|---|
| 15 Maggio 2026 | $0,6000 |
| 13 Febbraio 2026 | $0,6000 |
| 14 Novembre 2025 | $0,6000 |
| 15 Agosto 2025 | $0,5500 |
| 16 Maggio 2025 | $0,5500 |
| 14 Febbraio 2025 | $0,5500 |
| 15 Novembre 2024 | $0,5500 |
| 09 Agosto 2024 | $0,5100 |
| 09 Maggio 2024 | $0,5100 |
| 08 Febbraio 2024 | $0,5100 |
| 10 Novembre 2023 | $0,5100 |
| 10 Agosto 2023 | $0,4850 |
| 11 Maggio 2023 | $0,4850 |
| 09 Febbraio 2023 | $0,4850 |
| 10 Novembre 2022 | $0,4850 |
| 12 Agosto 2022 | $0,4600 |
| 13 Maggio 2022 | $0,4600 |
| 11 Febbraio 2022 | $0,4600 |
| 01 Dicembre 2021 | $1,2700 |
| 12 Novembre 2021 | $0,4600 |
COR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
- Acquisto forte 5 25,0%
- Compra 10 50,0%
- Mantieni 5 25,0%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
12 analisti · 2026-08-13Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Settembre 2026 | $4.48 | $4.39 | 0.09% |
| 30 Giugno 2026 | $4.48 | $4.39 | 0.09% |
| 31 Marzo 2026 | $4.75 | $4.86 | -0.11% |
| 31 Dicembre 2025 | $4.08 | $4.08 | 0.00% |
| 30 Settembre 2025 | $3.84 | $3.82 | 0.02% |
| 30 Giugno 2025 | $4.00 | $3.88 | 0.12% |
| 31 Marzo 2025 | $4.42 | $4.15 | 0.27% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Cost of Revenue | $309.85B | $284.05B | $253.21B | $230.29B | $207.05B | $184.70B | $174.45B | $163.33B | $148.60B | $142.58B | $132.43B | $116.59B | |
| Gross Profit | $11.48B | $9.91B | $8.96B | $8.30B | $6.94B | $5.19B | $5.14B | $4.61B | $4.55B | $4.27B | $3.53B | $2.98B | |
| SG&A Expense | $6.49B | $5.66B | $5.31B | $4.85B | $3.59B | $2.77B | $2.66B | $2.46B | $2.13B | $2.09B | $1.91B | $1.58B | |
| Operating Expenses | $6.99B | $6.09B | $5.72B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B | $-5.14B | $1.11B | $1.44B | $1.06B | $1.53B | $422M | $782M | |
| Other Non-op | $-79M | $-14M | $49M | $27M | $42M | $2M | $13M | $-25M | $3M | $5M | $-14M | $4M | |
| Pretax Income | $2.26B | $2.00B | $2.16B | $2.18B | $2.22B | $-5.29B | $967M | $1.18B | $918M | $1.39B | $269M | $670M | |
| Income Tax | $691M | $485M | $428M | $517M | $677M | $-1.89B | $113M | $-438M | $553M | $-37M | $407M | $388M | |
| Net Income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| EPS (Basic) | $8.02 | $7.60 | $8.62 | $8.15 | $7.48 | $-16.65 | $4.07 | $7.61 | $1.67 | $6.73 | $-0.63 | $1.21 | |
| EPS (Diluted) | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | $-16.65 | $4.04 | $7.53 | $1.64 | $6.32 | $-0.63 | $1.16 | |
| Shares (Basic) | 193,820,000 | 198,503,000 | 202,511,000 | 208,472,000 | 205,919,000 | 204,783,000 | 210,165,000 | 217,872,000 | 218,375,000 | 212,206,000 | 217,786,000 | 227,367,000 | |
| Shares (Diluted) | 195,214,000 | 200,284,000 | 204,591,000 | 211,210,000 | 208,465,000 | 204,783,000 | 211,840,000 | 220,336,000 | 221,602,000 | 225,959,000 | 217,786,000 | 235,405,000 | |
| EBITDA | $3.68B | $3.27B | $3.30B | $3.06B | $2.86B | $-4.74B | $1.57B | $1.91B | $1.46B | $1.89B | $661M | $964M |
Stato Patrimoniale 29
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.36B | $3.13B | $2.59B | $3.39B | $2.55B | $4.60B | $3.37B | $2.49B | $2.44B | $2.74B | $2.17B | $1.81B | |
| Receivables | $25.23B | $23.87B | $20.91B | $18.45B | $18.17B | $13.85B | $12.39B | $11.31B | $10.30B | $9.18B | $8.22B | $6.31B | |
| Inventory | $20.49B | $19.00B | $17.45B | $15.56B | $15.37B | $12.59B | $11.06B | $11.92B | $11.46B | $10.72B | $9.76B | $8.59B | |
| Prepaid Expense | $539M | $539M | $449M | $488M | $854M | $189M | $157M | $169M | $103M | $210M | $189M | $85M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $85M | |
| Current Assets | $52.24B | $47.72B | $42.80B | $39.59B | $38.80B | $33.06B | $28.13B | $25.89B | $24.30B | $22.85B | $20.33B | $16.80B | |
| PP&E (Net) | $2.54B | $2.18B | $2.14B | $2.14B | $2.16B | $1.48B | $1.77B | $1.89B | $1.80B | $1.53B | $1.19B | $900M | |
| PP&E (Gross) | $5.73B | $5.22B | $4.74B | $4.39B | $4.08B | $3.24B | $3.35B | $3.41B | $3.09B | $2.62B | $2.14B | $1.69B | |
| Accum. Depreciation | $3.19B | $3.03B | $2.60B | $2.25B | $1.92B | $1.76B | $1.58B | $1.52B | $1.29B | $1.09B | $950M | $793M | |
| Goodwill | $13.68B | $9.32B | $9.57B | $8.50B | $9.03B | $6.71B | $6.71B | $6.66B | $6.04B | $5.99B | $4.14B | $2.95B | |
| Intangibles | $3.77B | $4.00B | $4.43B | $4.33B | $5.26B | $1.89B | $2.29B | $2.95B | $2.83B | $2.97B | $1.99B | $533M | |
| Other Non-current Assets | $4.15B | $3.64B | $3.42B | $1.76B | $1.79B | $780M | $269M | $271M | $338M | $296M | $298M | $351M | |
| Total Assets | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Accounts Payable | $54.72B | $50.94B | $45.84B | $40.19B | $38.01B | $31.71B | $28.39B | $26.84B | $25.40B | $23.93B | $20.89B | $15.59B | |
| Accrued Liabilities | $2.98B | $2.76B | $2.35B | $2.21B | $2.86B | $1.65B | $1.06B | $881M | $1.40B | $744M | $692M | $562M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Current Liabilities | $57.82B | $54.28B | $48.83B | $43.48B | $41.36B | $33.85B | $29.58B | $27.87B | $26.82B | $25.28B | $21.58B | $17.25B | |
| Capital Leases | $1.42B | $1.03B | $924M | $864M | $946M | $386M | $321M | $352M | $352M | $276M | $246M | · | |
| Deferred Tax | $1.62B | $1.64B | $1.66B | $1.62B | $1.69B | $686M | $1.86B | $1.83B | $2.49B | $2.21B | $1.94B | $241M | |
| Other Non-current Liabilities | $3.64B | $1.99B | $1.88B | $977M | $1.08B | $473M | $99M | $110M | $75M | $160M | $85M | $88M | |
| Long-term Debt | $7.66B | $4.39B | $4.79B | $5.70B | $6.68B | $4.12B | $4.17B | $177M | $3.44B | $4.19B | $3.49B | $2.00B | |
| Total Debt | $7.54B | $3.81B | $4.15B | $4.63B | $6.38B | $3.62B | $4.03B | $4.17B | $3.43B | $3.59B | $3.49B | $2.00B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $6.53B | $5.42B | $4.32B | $2.98B | $1.67B | $518M | $4.24B | $3.72B | $2.40B | $2.30B | $1.16B | $1.57B | |
| Treasury Stock | $10.33B | $9.82B | $8.25B | $7.02B | $6.47B | $6.51B | $6.10B | $5.43B | $4.76B | $4.40B | $4.15B | $2.31B | |
| AOCI | $-901M | $-989M | $-1.40B | $-1.83B | $-445M | $-109M | $-112M | $-79M | $-96M | $-114M | $-136M | $-52M | |
| Stockholders' Equity | $1.51B | $646M | $522M | $-212M | $223M | $-1.02B | $2.88B | $2.93B | $2.06B | $2.13B | $616M | $1.94B | |
| Liabilities + Equity | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Shares Outstanding | 193,937,673 | 194,943,968 | 200,814,804 | 206,203,817 | 208,089,298 | 204,226,465 | 206,760,654 | 213,217,882 | 217,993,598 | 220,050,502 | 206,891,873 | 221,908,650 |
Flusso di cassa 19
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.05B | $1.09B | $964M | $694M | $505M | $391M | $462M | $465M | $398M | $365M | $249M | $189M | |
| Stock-based Comp | $148M | $148M | $125M | $93M | $100M | $74M | $59M | $62M | $62M | $65M | $61M | $43M | |
| Deferred Tax | $60M | $-102M | $-119M | $196M | $335M | $-1.54B | $29M | $-796M | $319M | $-131M | $21M | $38M | |
| Amort. of Intangibles | $557M | $663M | $554M | $307M | $178M | $111M | $167M | $181M | $161M | $152M | $56M | $26M | |
| Restructuring | $229M | $234M | $230M | $63M | $82M | $6.81B | $330M | $184M | $959M | $103M | $38M | $8M | |
| Other Non-cash | $1.06B | $838M | $1.20B | $21M | $187M | $6.70B | $939M | $21M | $361M | $1.45B | $3.73B | $919M | |
| Operating Cash Flow | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B | $2.21B | $2.34B | $1.41B | $1.50B | $3.18B | $3.92B | $1.46B | |
| CapEx | $668M | $487M | $458M | $496M | $438M | $370M | $310M | $336M | $466M | $465M | $232M | $264M | |
| Investing Cash Flow | $-4.98B | $-618M | $-2.60B | $-368M | $-6.14B | $-380M | $-376M | $-1.11B | $-498M | $-3.17B | $-2.93B | $-384M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $1.10B | |
| Net Debt Issued | $-1.28B | · | · | · | $-835M | $-598M | $-511M | $-681M | $-750M | $-800M | $-500M | $566M | |
| Stock Issued | · | · | · | $0 | $0 | $66M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | $435M | $1.49B | $1.18B | $484M | $82M | $420M | $674M | $639M | $330M | $2.27B | $1.86B | $754M | |
| Net Stock Activity | $-435M | $-1.49B | $-1.18B | $-484M | $-82M | $-354M | $-674M | $-639M | $-330M | $-2.27B | $-1.86B | $-754M | |
| Dividends Paid | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M | |
| Financing Cash Flow | $2.25B | $-2.33B | $-2.22B | $-1.75B | $1.95B | $-604M | $-1.09B | $-243M | $-1.31B | $565M | $-632M | $-503M | |
| Net Change in Cash | $1.10B | $545M | $-841M | $523M | $-1.53B | $1.22B | $882M | $57M | $-307M | $574M | $359M | $578M | |
| Taxes Paid | $571M | $604M | $463M | $244M | $94M | $139M | $118M | $104M | $105M | $18M | $300M | $197M | |
| Free Cash Flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B | $1.84B | $2.03B | $1.07B | $1.04B | $2.71B | $3.69B | $1.20B |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% | 2.7% | 2.9% | 2.8% | 3.0% | 2.9% | 2.6% | 2.5% | |
| Operating Margin | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% | -2.7% | 0.62% | 0.86% | 0.69% | 1.0% | 0.31% | 0.65% | |
| Net Margin | 0.48% | 0.51% | 0.67% | 0.71% | 0.72% | -1.8% | 0.48% | 0.99% | 0.24% | 0.97% | -0.10% | 0.23% | |
| Pretax Margin | 0.70% | 0.68% | 0.82% | 0.91% | 1.0% | -2.8% | 0.54% | 0.70% | 0.60% | 0.95% | 0.20% | 0.56% | |
| EBITDA Margin | 1.1% | 1.1% | 1.3% | 1.3% | 1.3% | -2.5% | 0.88% | 1.1% | 0.95% | 1.3% | 0.49% | 0.81% | |
| ROA | 2.2% | 2.3% | 2.9% | 3.0% | 3.0% | -8.2% | 2.2% | 4.5% | 1.1% | 4.6% | -0.55% | 1.4% | |
| ROE | 144.3% | 258.4% | 1124.4% | 28805.8% | -387.1% | -366.5% | 29.4% | 66.4% | 17.4% | 104.0% | -10.5% | 13.0% | |
| ROIC | 20.2% | 37.0% | 40.2% | 40.9% | 24.8% | -126.9% | 14.2% | 27.9% | 7.7% | 27.4% | -5.0% | 8.3% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 | |
| LT Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.5 | 4.5 | 4.4 | 4.2 | 4.2 | 4.6 | 4.7 | 4.6 | 4.4 | 4.8 | 5.5 | 5.9 | |
| Inventory Turnover | 15.7 | 15.6 | 15.3 | 14.9 | 14.8 | 15.6 | 15.2 | 14.0 | 13.4 | 13.9 | 14.4 | 15.0 | |
| Receivables Turnover | 13.1 | 13.1 | 13.3 | 13.0 | 13.4 | 14.5 | 15.2 | 15.5 | 15.7 | 16.9 | 18.7 | 19.3 |
Tassi di Crescita 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.1% | 9.9% | 11.5% | 12.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 11.2% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 5.7% | -11.7% | 6.1% | 8.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -0.33% | 0.63% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3.0% | -13.5% | 2.7% | 10.3% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.9% | -0.67% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Net Income TTM | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| Market Cap | $60.61B | $43.88B | $36.14B | $27.91B | $24.86B | $19.79B | $17.02B | $19.66B | $18.04B | $17.78B | $19.65B | $17.15B | |
| Enterprise Value | $63.80B | $44.56B | $37.69B | $29.15B | $28.69B | $18.81B | $17.68B | $21.34B | $19.03B | $18.63B | $20.98B | $17.34B | |
| P/E | 39.3 | 29.9 | 21.1 | 16.8 | 16.2 | -5.8 | 20.4 | 12.2 | 50.5 | 12.8 | -150.8 | 66.6 | |
| P/S | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| P/B | 40.2 | 67.9 | 69.2 | -131.9 | 111.3 | -19.4 | 5.9 | 6.7 | 8.7 | 8.3 | 31.0 | 8.8 | |
| P / Cash Flow | 15.6 | 12.6 | 9.2 | 10.3 | 9.3 | 9.0 | 7.3 | 13.9 | 12.0 | 5.6 | 5.0 | 11.7 | |
| P / FCF | 18.9 | 14.6 | 10.5 | 12.6 | 11.2 | 10.8 | 8.4 | 18.3 | 17.4 | 6.5 | 5.3 | 14.3 | |
| EV / EBITDA | 17.3 | 13.6 | 11.4 | 9.5 | 10.0 | -4.0 | 11.2 | 11.2 | 13.1 | 9.9 | 31.8 | 18.0 | |
| EV / FCF | 19.9 | 14.9 | 10.9 | 13.2 | 12.9 | 10.2 | 8.7 | 19.9 | 18.3 | 6.9 | 5.7 | 14.5 | |
| EV / Revenue | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
| Dividend Yield | 0.72% | 0.95% | 1.1% | 1.4% | 1.5% | 1.7% | 2.0% | 1.7% | 1.8% | 1.6% | 1.3% | 1.2% | |
| Earnings Yield | 2.5% | 3.4% | 4.7% | 5.9% | 6.2% | -17.2% | 4.9% | 8.2% | 2.0% | 7.8% | -0.66% | 1.5% | |
| Payout Ratio | 28.1% | 27.6% | 22.9% | 23.1% | 23.8% | -10.1% | 39.6% | 20.1% | 87.9% | 20.2% | -188.2% | 77.6% | |
| Annual Payout | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M |
Conto Economico 15
| Metrica | Tendenza | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.75B | $78.36B | $85.93B | $83.73B | $80.66B | $75.45B | $81.49B | $79.05B | $74.24B | $68.41B | $72.25B | $68.92B | $66.95B | $63.46B | $62.85B | $61.17B | |
| Cost of Revenue | $81.15B | $74.77B | $82.86B | $80.77B | $77.76B | $72.39B | $78.93B | $76.56B | $71.83B | $65.88B | $69.78B | $66.67B | $64.68B | $61.16B | $60.70B | $59.19B | |
| Gross Profit | $3.61B | $3.59B | $3.07B | $2.95B | $2.91B | $3.06B | $2.56B | $2.49B | $2.41B | $2.54B | $2.47B | $2.25B | $2.26B | $2.30B | $2.15B | $1.99B | |
| SG&A Expense | $2.13B | $1.98B | $1.80B | $1.75B | $1.67B | $1.60B | $1.47B | $1.49B | $1.38B | $1.39B | $1.40B | $1.39B | $1.30B | $1.32B | $1.29B | $1.26B | |
| Operating Expenses | $2.28B | $2.11B | $1.93B | $1.88B | $1.80B | $1.72B | $1.59B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $1.12B | $1.14B | $760M | $19M | $868M | $1.04B | $706M | $127M | $672M | $553M | $823M | $477M | $670M | $561M | $633M | $455M | |
| Other Non-op | $17M | $1.09B | $21M | $-128M | $110M | $-4M | $-58M | $20M | $-13M | $-22M | $1M | $30M | $-3M | $16M | $6M | $-21M | |
| Pretax Income | $996M | $2.09B | $709M | $-187M | $896M | $929M | $620M | $125M | $628M | $467M | $783M | $446M | $609M | $512M | $593M | $382M | |
| Income Tax | $220M | $459M | $143M | $146M | $207M | $211M | $127M | $118M | $141M | $46M | $180M | $97M | $130M | $84M | $117M | $84M | |
| Net Income | $764M | $1.64B | $560M | $-340M | $687M | $718M | $489M | $3M | $483M | $421M | $602M | $351M | $480M | $435M | $480M | $295M | |
| EPS (Basic) | $3.95 | $8.44 | $2.88 | $-1.75 | $3.55 | $3.70 | $2.52 | $0.04 | $2.44 | $2.11 | $3.01 | $1.75 | $2.37 | $2.15 | $2.35 | $1.43 | |
| EPS (Diluted) | $3.94 | $8.40 | $2.87 | $-1.74 | $3.52 | $3.68 | $2.50 | $0.04 | $2.42 | $2.09 | $2.98 | $1.72 | $2.35 | $2.13 | $2.33 | $1.40 | |
| Shares (Basic) | 193,147,000 | 194,545,000 | 194,219,000 | -387,556,000 | 193,822,000 | 193,796,000 | 193,758,000 | -399,244,000 | 198,260,000 | 199,406,000 | 200,081,000 | -406,186,000 | 202,349,000 | 202,316,000 | 204,032,000 | -418,212,000 | |
| Shares (Diluted) | 193,944,000 | 195,383,000 | 195,319,000 | -390,298,000 | 195,230,000 | 195,094,000 | 195,188,000 | -402,777,000 | 200,047,000 | 201,177,000 | 201,837,000 | -410,367,000 | 204,375,000 | 204,256,000 | 206,327,000 | -423,687,000 | |
| EBITDA | $1.39B | $1.39B | $1.02B | · | $868M | $1.04B | $706M | · | $672M | $553M | $823M | · | $670M | $561M | $633M | · |
Stato Patrimoniale 27
| Metrica | Tendenza | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.82B | $2.18B | $1.75B | $4.36B | $2.23B | $1.98B | $3.22B | $3.13B | $3.31B | $2.07B | $2.87B | $2.59B | $1.39B | $1.54B | $1.69B | $3.39B | |
| Receivables | $25.45B | $24.89B | $25.98B | $25.23B | $24.56B | $23.72B | $24.55B | $23.87B | $24.05B | $22.64B | $21.58B | · | $20.80B | $19.49B | $18.63B | · | |
| Inventory | $21.03B | $20.01B | $24.08B | $20.49B | $20.14B | $18.97B | $20.51B | $19.00B | $18.30B | $17.63B | $18.65B | · | $16.85B | $16.96B | $16.78B | · | |
| Prepaid Expense | $636M | $637M | $678M | $539M | $451M | $575M | $516M | $539M | $460M | $512M | $493M | · | $493M | $488M | $1.99B | · | |
| Current Assets | $55.34B | $53.14B | $54.15B | $52.24B | $48.81B | $46.53B | $49.99B | $47.72B | $47.31B | $44.16B | $44.86B | · | $40.99B | $39.99B | $40.71B | · | |
| PP&E (Net) | $2.84B | $2.81B | $2.45B | $2.54B | $2.43B | $2.30B | $2.10B | $2.18B | $2.08B | $2.09B | $2.12B | · | $2.15B | $2.15B | $2.14B | · | |
| PP&E (Gross) | · | · | · | $5.73B | · | · | · | $5.22B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $3.19B | · | · | · | $3.03B | · | · | · | · | · | · | · | · | |
| Goodwill | $16.52B | $16.45B | $13.73B | $13.68B | $14.33B | $14.09B | $9.18B | $9.32B | $9.61B | $9.62B | $9.66B | $9.57B | $9.66B | $9.63B | $8.60B | $8.50B | |
| Intangibles | $5.93B | $6.05B | $3.68B | $3.77B | $3.93B | $3.86B | $3.68B | $4.00B | $4.01B | $4.18B | $4.38B | · | $4.77B | $4.88B | $4.43B | · | |
| Other Non-current Assets | $3.01B | $3.01B | $4.14B | $4.15B | $4.23B | $4.17B | $3.89B | $3.64B | $3.53B | $3.57B | $3.46B | · | $3.40B | $1.88B | $1.80B | · | |
| Total Assets | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Accounts Payable | $54.70B | $51.88B | $56.06B | $54.72B | $51.04B | $50.11B | $49.91B | $50.94B | $49.88B | $46.32B | $47.74B | · | $43.75B | $42.73B | $41.76B | · | |
| Accrued Liabilities | $3.35B | $3.20B | $2.73B | $2.98B | $2.72B | $2.45B | $2.39B | $2.76B | $2.53B | $2.37B | $2.44B | · | $2.17B | $2.07B | $2.01B | · | |
| Current Liabilities | $59.20B | $56.13B | $59.13B | $57.82B | $53.96B | $53.33B | $54.51B | $54.28B | $52.97B | $49.76B | $50.77B | · | $46.78B | $45.07B | $44.76B | · | |
| Capital Leases | · | · | · | $1.42B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | |
| Deferred Tax | $1.79B | $1.75B | $1.64B | $1.62B | $1.61B | $1.62B | $1.59B | $1.64B | $1.61B | $1.70B | $1.69B | · | $1.72B | $1.74B | $1.63B | · | |
| Other Non-current Liabilities | $3.97B | $3.79B | $3.70B | $3.64B | $3.54B | $3.42B | $2.06B | $1.99B | $1.93B | $1.96B | $1.91B | · | $1.86B | $1.06B | $992M | · | |
| Long-term Debt | $11.72B | $12.39B | $7.92B | $7.66B | $8.24B | $7.86B | $8.15B | $4.39B | $4.73B | $5.25B | $4.78B | · | · | · | · | · | |
| Total Debt | $11.44B | $12.18B | $7.58B | · | $8.04B | $7.09B | $5.94B | · | $4.17B | $4.18B | $4.19B | · | $4.16B | $4.67B | $4.66B | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | |
| Retained Earnings | $9.14B | $8.49B | $6.97B | $6.53B | $6.98B | $6.40B | $5.79B | $5.42B | $5.51B | $5.13B | $4.82B | · | $4.07B | $3.69B | $3.36B | · | |
| Treasury Stock | $11.45B | $10.44B | $10.43B | $10.33B | $10.33B | $10.33B | $10.28B | $9.82B | $9.30B | $8.75B | $8.69B | · | $7.97B | $7.87B | $7.86B | · | |
| AOCI | $-980M | $-961M | $-905M | $-901M | $-844M | $-1.20B | $-1.40B | $-989M | $-1.28B | $-1.26B | $-1.14B | · | $-1.23B | $-1.32B | $-1.41B | · | |
| Stockholders' Equity | $3.05B | $3.40B | $1.91B | $1.51B | $1.98B | $1.01B | $227M | $646M | $925M | $1.08B | $912M | · | $686M | $282M | $-178M | · | |
| Liabilities + Equity | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Shares Outstanding | 190,826,409 | 194,560,641 | 194,521,885 | 193,937,673 | 193,860,959 | 193,783,768 | 193,849,411 | 194,943,968 | 197,008,633 | 199,388,633 | 199,461,864 | · | 202,109,227 | 202,410,686 | 202,225,546 | · |
Flusso di cassa 17
| Metrica | Tendenza | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $269M | $249M | $260M | $259M | $254M | $260M | $278M | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $29M | $28M | $66M | $26M | $23M | $28M | $70M | $35M | $22M | $28M | $63M | $25M | $21M | $23M | $56M | $16M | |
| Deferred Tax | $55M | $178M | $14M | $55M | $-17M | $26M | $-5M | $4M | $-70M | $-40M | $3M | $-29M | $-28M | $-49M | $-12M | $139M | |
| Amort. of Intangibles | $119M | $117M | $126M | $127M | $126M | $138M | $166M | $167M | $165M | $166M | $166M | $171M | $170M | $141M | $72M | $73M | |
| Restructuring | $61M | $41M | $14M | $89M | $42M | $53M | $46M | $81M | $42M | $76M | $34M | $52M | $64M | $97M | $16M | $-146M | |
| Other Non-cash | · | · | $-3.21B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.65B | $1.34B | $-2.31B | $3.13B | $109M | $3.35B | $-2.72B | $1.00B | $2.48B | $-878M | $885M | $1.83B | $745M | $630M | $710M | $1.16B | |
| CapEx | $226M | $166M | $119M | $250M | $183M | $129M | $106M | $182M | $118M | $113M | $74M | $175M | $104M | $103M | $76M | $174M | |
| Investing Cash Flow | $-240M | $-4.87B | $-299M | $-322M | $-235M | $-4.08B | $-343M | $-242M | $-144M | $-166M | $-66M | $-183M | $-819M | $-89M | $-1.51B | $-175M | |
| Debt Issued | · | · | · | · | · | · | · | · | $53M | $545M | $90M | · | $89M | $13M | $55M | · | |
| Net Debt Issued | · | · | $-132M | · | · | · | $-45M | · | · | · | $6M | · | · | · | $2M | · | |
| Stock Repurchased | · | · | · | $71.0K | $0 | $50M | $385M | $505M | $550M | $51M | $386M | $274M | $100M | $0 | $807M | $235M | |
| Net Stock Activity | · | · | · | · | · | · | $-385M | · | · | · | $-386M | · | · | · | $-807M | · | |
| Dividends Paid | $117M | $117M | $127M | $108M | $107M | $111M | $111M | $101M | $103M | $107M | $106M | $98M | $99M | $102M | $100M | $96M | |
| Financing Cash Flow | $-1.77B | $3.98B | $43M | $-684M | $215M | $-492M | $3.21B | $-957M | $-1.15B | $323M | $-552M | $-407M | $-82M | $-769M | $-964M | $-673M | |
| Net Change in Cash | $629M | $428M | $-2.59B | $2.12B | $97M | $-1.22B | $97M | $-179M | $1.19B | $-751M | $283M | $1.20B | $-140M | $-224M | $-1.68B | $291M | |
| Free Cash Flow | · | · | $-2.42B | · | · | · | $-2.82B | · | · | · | $811M | · | · | · | $634M | · |
Redditività 8
| Metrica | Tendenza | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 4.3% | 4.6% | 3.6% | · | 3.6% | 4.1% | 3.1% | · | 3.2% | 3.7% | 3.4% | · | 3.4% | 3.6% | 3.4% | · | |
| Operating Margin | 1.3% | 1.5% | 0.88% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| Net Margin | 0.90% | 2.1% | 0.65% | · | 0.85% | 0.95% | 0.60% | · | 0.65% | 0.62% | 0.83% | · | 0.72% | 0.69% | 0.76% | · | |
| Pretax Margin | 1.2% | 2.7% | 0.82% | · | 1.1% | 1.2% | 0.76% | · | 0.85% | 0.68% | 1.1% | · | 0.91% | 0.81% | 0.94% | · | |
| EBITDA Margin | 1.6% | 1.8% | 1.2% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| ROA | 0.97% | 2.1% | 0.76% | · | 0.98% | 1.1% | 0.73% | · | 0.76% | 0.69% | 0.98% | · | 0.81% | 0.75% | 0.83% | · | |
| ROE | 30.3% | 74.4% | 52.4% | · | 47.3% | 68.5% | 85.9% | · | 60.0% | 61.7% | 164.0% | · | 105.4% | 104.7% | 1513.0% | · | |
| ROIC | 6.0% | 5.7% | 6.4% | · | 6.7% | 9.9% | 9.1% | · | 10.2% | 9.5% | 12.4% | · | 10.9% | 9.5% | 11.3% | · |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | |
| Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · | |
| LT Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · |
Efficienza 3
| Metrica | Tendenza | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | |
| Inventory Turnover | 3.9 | 3.8 | 3.7 | · | 4.0 | 4.0 | 4.0 | · | 4.1 | 3.8 | 3.9 | · | 4.0 | 3.8 | 3.7 | · | |
| Receivables Turnover | 3.4 | 3.2 | 3.4 | · | 3.3 | 3.3 | 3.5 | · | 3.3 | 3.2 | 3.6 | · | 3.4 | 3.4 | 3.5 | · |
Valutazione (TTM) 14
| Metrica | Tendenza | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $329.71B | $320.41B | $323.54B | · | $311.85B | $299.60B | $296.40B | · | $281.86B | $271.07B | $265.50B | · | $253.32B | $244.09B | $240.26B | · | |
| Net Income TTM | $3.65B | $3.61B | $2.45B | · | $2.38B | $2.11B | $1.99B | · | $1.99B | $1.94B | $2.00B | · | $1.80B | $1.87B | $1.88B | · | |
| Market Cap | $54.00B | $61.12B | $65.70B | · | $58.13B | $53.89B | $43.55B | · | $44.39B | $48.45B | $40.97B | · | $38.89B | $32.41B | $33.51B | · | |
| Enterprise Value | $62.63B | $71.13B | $71.53B | · | $63.94B | $59.00B | $46.27B | · | $45.25B | $50.56B | $42.28B | · | $41.66B | $35.54B | $36.47B | · | |
| P/E | 15.1 | 17.0 | 26.9 | · | 24.7 | 26.0 | 22.5 | · | 22.9 | 25.4 | 21.0 | · | 22.0 | 17.8 | 18.5 | · | |
| P/S | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | |
| P/B | 17.7 | 18.0 | 34.4 | · | 29.4 | 53.2 | 192.2 | · | 48.0 | 44.7 | 44.9 | · | 56.7 | 115.0 | -188.1 | · | |
| P / Cash Flow | · | · | -28.5 | · | · | · | -16.0 | · | · | · | 46.3 | · | · | · | 47.2 | · | |
| P / FCF | · | · | -27.1 | · | · | · | -15.4 | · | · | · | 50.5 | · | · | · | 52.8 | · | |
| EV / EBITDA | 45.1 | 51.1 | 70.1 | · | 73.7 | 56.9 | 65.5 | · | 67.3 | 91.4 | 51.4 | · | 62.2 | 63.4 | 57.6 | · | |
| EV / FCF | · | · | -29.5 | · | · | · | -16.4 | · | · | · | 52.1 | · | · | · | 57.5 | · | |
| EV / Revenue | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | |
| Earnings Yield | 6.6% | 5.9% | 3.7% | · | 4.0% | 3.8% | 4.5% | · | 4.4% | 3.9% | 4.8% | · | 4.5% | 5.6% | 5.4% | · | |
| Payout Ratio | · | · | 22.6% | · | · | · | 22.7% | · | · | · | 17.6% | · | · | · | 20.8% | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Ricavi | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B |
| Margine Lordo % | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% |
| Margine Operativo % | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% |
| Utile netto | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B |
| EPS Diluito | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 |
Stato Patrimoniale
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 |
| Rapporto corrente | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Quick Ratio | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Flusso di cassa
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B |
Ultime notizie Notizie recenti che menzionano questa società
- IYK, MCK, CTVA, COR: ETF Outflow Alert
- Rapport sugli acquisti interni di venerdì 29/5: SCHW, COR
- Cencora (COR) Emerge Come Leader Sanitaria con Fondamentali Solidi e Rivalutazione Strategica
- Cencora Risultati Trimestrali Q2 Highlights
- Cencora Inc Q2 26 Conference Call sugli utili 8:30 A.m. ET
- Cosa devi sapere prima del rilascio degli utili di Cencora
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 1.489 filer · $31.4B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 102 (-56 vs trimestre precedente) | 172 (+41 vs trimestre precedente) | 434 (-101 vs trimestre precedente) | 595 (+65 vs trimestre precedente) | +8.4M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3.502.993.290 | 12.378.943 | 11,15% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.719.934.713 | 9.611.756 | 8,66% | Azioni |
| STATE STREET CORP | $2.624.351.709 | 9.273.983 | 8,35% | Azioni |
| Walgreens Boots Alliance, Inc. | $2.240.779.050 | 7.473.000 | 7,13% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.358.112.555 | 4.819.419 | 4,32% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $1.231.165.897 | 4.350.717 | 3,92% | Azioni |
| FMR LLC | $850.228.724 | 3.004.554 | 2,71% | Azioni |
| NORGES BANK | $700.042.999 | 2.473.825 | 2,23% | Azioni |
| Capital Research Global Investors | $560.283.987 | 1.979.942 | 1,78% | Azioni |
| Carmignac Gestion | $494.462.712 | 1.747.363 | 1,57% | Azioni |
| Mitsubishi UFJ Asset Management Co., Ltd. | $483.772.138 | 1.709.563 | 1,54% | Azioni |
| Mawer Investment Management Ltd. | $421.312.792 | 1.488.843 | 1,34% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $410.282.013 | 1.449.862 | 1,31% | Azioni |
| CITADEL ADVISORS LLC | $347.541.038 | 1.228.147 | 1,11% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $338.738.459 | 1.197.038 | 1,08% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $315.929.430 | 1.116.828 | 1,01% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $313.668.332 | 1.108.447 | 1,00% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $313.605.793 | 1.108.226 | 1,00% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $294.327.781 | 1.040.101 | 0,94% | Azioni |
| Sumitomo Mitsui Trust Group, Inc. | $293.610.144 | 1.037.565 | 0,93% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $268.966.547 | 950.479 | 0,86% | Azioni |
| LAZARD ASSET MANAGEMENT LLC | $261.088.180 | 922.638 | 0,83% | Azioni |
| Caisse de depot et placement du Quebec | $258.709.937 | 914.234 | 0,82% | Azioni |
| Boston Partners | $231.295.970 | 817.358 | 0,74% | Azioni |
| National Pension Service | $208.758.025 | 737.713 | 0,66% | Azioni |
| GOLDMAN SACHS GROUP INC | $208.660.680 | 737.369 | 0,66% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $205.281.694 | 653.472 | 0,65% | Azioni |
| NORDEA INVESTMENT MANAGEMENT AB | $180.668.066 | 644.564 | 0,58% | Azioni |
| Burgundy Asset Management Ltd. | $174.893.972 | 599.753 | 0,56% | Azioni |
| Balyasny Asset Management L.P. | $172.225.024 | 608.612 | 0,55% | Azioni |
| Point72 Asset Management, L.P. | $171.131.023 | 604.746 | 0,54% | Azioni |
| Assenagon Asset Management S.A. | $166.084.924 | 586.914 | 0,53% | Azioni |
| Squarepoint Ops LLC | $154.024.599 | 544.295 | 0,49% | Azioni |
| Swiss National Bank | $147.506.155 | 521.260 | 0,47% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $141.101.751 | 498.628 | 0,45% | Azioni |
| Swedbank AB | $134.859.213 | 476.568 | 0,43% | Azioni |
| TimesSquare Capital Management, LLC | $132.589.070 | 422.070 | 0,42% | Azioni |
| Legal & General Group Plc | $129.674.734 | 458.247 | 0,41% | Azioni |
| RHUMBLINE ADVISERS | $123.138.883 | 435.151 | 0,39% | Azioni |
| Vanguard Global Advisers, LLC | $120.449.305 | 425.646 | 0,38% | Azioni |
| BlackRock, Inc. | $119.463.969 | 422.164 | 0,38% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $117.740.633 | 416.074 | 0,37% | Azioni |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $113.208.499 | 400.058 | 0,36% | Azioni |
| California Public Employees Retirement System | $110.655.367 | 391.036 | 0,35% | Azioni |
| BANK OF AMERICA CORP /DE/ | $105.342.134 | 372.260 | 0,34% | Azioni |
| SEB Asset Management AB | $104.030.095 | 367.624 | 0,33% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $101.511.435 | 358.723 | 0,32% | Azioni |
| VANGUARD GROUP INC | $100.694.421 | 298.133 | 0,32% | Azioni |
| Walleye Capital LLC | $98.419.595 | 347.797 | 0,31% | Azioni |
| MIZUHO MARKETS AMERICAS LLC | $96.213.200 | 340.000 | 0,31% | Azioni |
| JOHNSON INVESTMENT COUNSEL INC | $93.893.214 | 331.802 | 0,30% | Azioni |
| STOREBRAND ASSET MANAGEMENT AS | $93.049.484 | 328.820 | 0,30% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $88.657.847 | 282.224 | 0,28% | Azioni |
| Cornerstone Investment Partners, LLC | $86.260.510 | 304.829 | 0,27% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85.771.238 | 303.100 | 0,27% | Opzione Call |
| JONES FINANCIAL COMPANIES LLLP | $85.147.559 | 297.583 | 0,27% | Azioni |
| CIBC Private Wealth Group LLC | $83.133.772 | 266.003 | 0,26% | Azioni |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $81.593.038 | 288.335 | 0,26% | Azioni |
| FIL Ltd | $79.588.408 | 281.251 | 0,25% | Azioni |
| LPL Financial LLC | $76.804.992 | 271.415 | 0,24% | Azioni |
| TD Asset Management Inc | $76.770.210 | 271.292 | 0,24% | Azioni |
| BANK OF MONTREAL /CAN/ | $70.057.359 | 247.570 | 0,22% | Azioni |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $69.812.864 | 246.706 | 0,22% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $68.792.155 | 243.099 | 0,22% | Azioni |
| CITADEL ADVISORS LLC | $68.622.650 | 242.500 | 0,22% | Opzione Call |
| FIRST MANHATTAN CO. LLC. | $68.126.586 | 240.747 | 0,22% | Azioni |
| AMERIPRISE FINANCIAL INC | $67.675.233 | 239.152 | 0,22% | Azioni |
| TREMBLANT CAPITAL GROUP | $67.203.788 | 237.486 | 0,21% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $64.886.066 | 229.296 | 0,21% | Azioni |
| EARNEST PARTNERS LLC | $63.127.461 | 223.081 | 0,20% | Azioni |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | $60.624.220 | 214.235 | 0,19% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $60.395.855 | 213.428 | 0,19% | Azioni |
| JENNISON ASSOCIATES LLC | $60.017.829 | 212.092 | 0,19% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $59.924.694 | 211.763 | 0,19% | Azioni |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $57.032.921 | 201.544 | 0,18% | Azioni |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $52.864.060 | 186.812 | 0,17% | Azioni |
| BARCLAYS PLC | $51.304.557 | 181.301 | 0,16% | Azioni |
| Mitsubishi UFJ Trust & Banking Corp | $51.082.984 | 180.518 | 0,16% | Azioni |
| PFA Pension, Forsikringsaktieselskab | $50.217.651 | 177.460 | 0,16% | Azioni |
| MARSHALL WACE, LLP | $50.044.447 | 176.848 | 0,16% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $49.878.621 | 176.262 | 0,16% | Azioni |
| Sio Capital Management, LLC | $49.121.932 | 173.588 | 0,16% | Azioni |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $48.634.175 | 162.136 | 0,15% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $48.419.177 | 171.284 | 0,15% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $47.513.047 | 151.248 | 0,15% | Azioni |
| AVIVA PLC | $47.242.096 | 166.945 | 0,15% | Azioni |
| Jefferies Financial Group Inc. | $46.356.935 | 163.817 | 0,15% | Azioni |
| Brandywine Global Investment Management, LLC | $45.181.831 | 133.773 | 0,14% | Azioni |
| Asset Management One Co., Ltd. | $44.176.566 | 140.627 | 0,14% | Azioni |
| Trajan Wealth LLC | $43.325.888 | 153.106 | 0,14% | Azioni |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $43.248.965 | 152.834 | 0,14% | Azioni |
| Ensign Peak Advisors, Inc | $42.869.206 | 151.492 | 0,14% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $42.457.470 | 150.037 | 0,14% | Azioni |
| UBS Group AG | $41.937.353 | 148.199 | 0,13% | Azioni |
| Freestone Grove Partners LP | $41.195.379 | 145.577 | 0,13% | Azioni |
| Qube Research & Technologies Ltd | $40.558.109 | 143.325 | 0,13% | Azioni |
| VAN ECK ASSOCIATES CORP | $40.356.344 | 142.612 | 0,13% | Azioni |
| MACKENZIE FINANCIAL CORP | $40.057.234 | 141.555 | 0,13% | Azioni |
| DONALDSON CAPITAL MANAGEMENT, LLC | $38.839.791 | 137.253 | 0,12% | Azioni |
| ROYAL BANK OF CANADA | $37.959.000 | 134.139 | 0,12% | Azioni |
Insider aziendali 49 insider · 23 dirigenti · 27 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert P. Mauch | President & CEO | 18 Giugno 2025 M | 44.094 | 0 | 0 | $0 |
| David R Yost | CEO | 17 Maggio 2011 M | 1.530.341 | 0 | 0 | $0 |
| Eva C Boratto | Chief Financial Officer | 29 Giugno 2026 A | — | 0 | 0 | $0 |
| Tim G. Guttman | Chief Financial Officer | 09 Novembre 2018 M | 53.505 | 0 | 0 | $0 |
| Michael D Dicandilo | Executive VP & CFO | 02 Maggio 2011 M | 89.698 | 0 | 0 | $0 |
| Kurt J Hilzinger | President & COO | 15 Febbraio 2007 A | 176.400 | 0 | 0 | $0 |
| Elizabeth S Campbell | Executive Vice President | 30 Giugno 2026 A | 30.756 | 0 | 0 | $0 |
| Silvana Battaglia | Executive Vice President | 30 Giugno 2026 A | 23.624 | 0 | 0 | $0 |
| Steven H Collis | Executive Chairman | 16 Settembre 2025 M | 305.913 | 0 | 2 | $-13.314.729 |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 29 Maggio 2025 S | 17.154 | 0 | 0 | $0 |
| Leslie E Donato | EVP & Chief Strategy Officer | 28 Giugno 2024 A | 9.525 | 0 | 0 | $0 |
| Gina Clark | Executive Vice President | 31 Maggio 2024 S | 13.284 | 0 | 0 | $0 |
| John G. Chou | Executive Vice President | 20 Dicembre 2021 G | 81.367 | 0 | 0 | $0 |
| Kathy H. Gaddes | Executive Vice President | 21 Febbraio 2020 M | 6.906 | 0 | 0 | $0 |
| Dale Danilewitz | Executive Vice President | 23 Maggio 2019 S | 1.085 | 0 | 0 | $0 |
| Howell Peyton R | Executive Vice President | 04 Aprile 2018 M | 47.989 | 0 | 0 | $0 |
| Sun Park | Executive Vice President | 17 Novembre 2017 F | 3.010 | 0 | 0 | $0 |
| James Frary | Executive Vice President | 09 Novembre 2016 A | 34.195 | 0 | 0 | $0 |
| Lawrence Marsh | Executive Vice President | 29 Aprile 2016 F | 8.897 | 0 | 0 | $0 |
| David W Neu | Executive Vice President | 13 Novembre 2015 F | 5.224 | 0 | 0 | $0 |
| June Barry | Executive Vice President | 13 Novembre 2015 M | 4.068 | 0 | 0 | $0 |
| Jeanne B. Fisher | Senior Vice President | 01 Febbraio 2010 M | 27.190 | 0 | 0 | $0 |
| Terrance P Haas | Senior Vice President | 27 Febbraio 2008 A | 25.728 | 0 | 0 | $0 |
| Lauren M Tyler | Direttore | 31 Luglio 2026 A | 4.456 | 1 | 0 | $148.626 |
| Dennis M Nally | Direttore | 31 Luglio 2026 A | 13.188 | 0 | 0 | $0 |
| Ellen Cooper | Direttore | 31 Luglio 2026 A | 893 | 0 | 0 | $0 |
| Dermot Mark Durcan | Direttore | 18 Giugno 2026 P | 31.767 | 2 | 0 | $2.161.800 |
| Lori Ryerkerk | Direttore | 01 Luglio 2025 A | 516 | 0 | 0 | $0 |
| Werner Baumann | Direttore | 01 Maggio 2025 A | 2.896 | 0 | 0 | $0 |
| Redonda Miller | Direttore | 06 Marzo 2025 A | 3.194 | 0 | 0 | $0 |
| Frank Clyburn | Direttore | 06 Marzo 2025 A | 1.157 | 0 | 0 | $0 |
| Lorence H. Kim | Direttore | 06 Marzo 2025 A | 3.524 | 0 | 0 | $0 |
| Richard W Gochnauer | Direttore | 11 Marzo 2024 M | 28.762 | 0 | 0 | $0 |
| Kathleen W Hyle | Direttore | 11 Marzo 2024 M | 24.406 | 0 | 0 | $0 |
| Henry Wadsworth Mcgee III | Direttore | 09 Marzo 2023 A | 20.479 | 0 | 0 | $0 |
| Jane E Henney MD | Direttore | 05 Marzo 2023 M | 24.685 | 0 | 0 | $0 |
| Michael J Long | Direttore | 05 Marzo 2023 M | 17.724 | 0 | 0 | $0 |
| Douglas R Conant | Direttore | 04 Marzo 2019 M | 8.062 | 0 | 0 | $0 |
| Richard C Gozon | Direttore | 29 Febbraio 2016 M | 51.484 | 0 | 0 | $0 |
| Edward E Hagenlocker | Direttore | 02 Marzo 2015 M | 3.351 | 0 | 0 | $0 |
| Charles H Cotros | Direttore | 07 Dicembre 2012 M | 26.773 | 0 | 0 | $0 |
| Lawrence J Wilson | Direttore | 01 Maggio 2009 A | 35.942 | 0 | 0 | $0 |
| Rodney H Brady | Direttore | 19 Febbraio 2007 A | 52.746 | 0 | 0 | $0 |
| James R Mellor | Direttore | 03 Gennaio 2006 M | 32.246 | 0 | 0 | $0 |
| Robert E Martini | Direttore | 23 Gennaio 2004 G | 1.602.739 | 0 | 0 | $0 |
| Francis G Rodgers | Direttore | 03 Novembre 2003 A | 7.918 | 0 | 0 | $0 |
| AMERISOURCEBERGEN CORP | Proprietario del 10% | 31 Luglio 2007 J | 0 | 0 | 0 | $0 |
| James F Cleary | — | 11 Marzo 2026 M | 160.357 | 0 | 0 | $0 |
| Lon R Greenberg | — | 05 Marzo 2026 A | 18.408 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Walgreens Boots Alliance Holdings LLC, WBA Investments, Inc., Walgreens Boots Alliance, Inc. ×21 depositi | 09 Giugno 2025 | 4,96% | Modifica | — | SEC |
| AB Acquisitions Holdings Limited, Alliance Santé Participations S.A., NEWCIP S.A., Stefano Pessina, KKR Sprint (2006) Limited, KKR 2006 Fund (Overseas), Limited Partnership, KKR Associates 2006 (Overseas), Limited Partnership, KKR 2006 Limited, KKR Sprint (European II) Limited, KKR European Fund II, Limited Partnership, KKR Associates Europe II, Limited Partnership, KKR Europe II Limited, KKR Sprint (KPE) Limited, KKR PEI Investments, L.P., KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts | 23 Gennaio 2015 | — | Deposito iniziale | — | SEC |
| WAB Holdings LLC, Walgreens Pharmacy Strategies, LLC, Bond Drug Company of Illinois, LLC, Walgreen Eastern Co., Inc., Walgreen Arizona Drug Co., Walgreen Hastings Co., Walgreen International Investments LLC, WBA Investments, LLC, Walgreen Co., Alliance Boots Luxembourg S.à r.l., Alliance Boots Holdings Limited, AB Acquisitions UK Holdco 7 Limited, AB Acquisitions Limited, Alliance Boots International Limited, Alliance Boots Limited, AB Acquisitions UK Topco Limited, AB Acquisitions Luxco 1 S.à r.l., Alliance Boots GmbH, Walgreen Swiss International GmbH, Ontario Holdings WBA Limited, Walgreen International S.à r.l., Superior Bermuda GP, Superior Luxco 3 S.à r.l., Walgreens Boots Alliance Scottish LP, WBA 1 Scottish LLP, Superior Luxco 2 S.à r.l., Superior Luxco 1 S.à r.l., Walgreen Investments Luxembourg SCS, Walgreen Investments Co, Walgreens Boots Alliance, Inc. ×2 depositi | 16 Gennaio 2015 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 212 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| JMID · Janus Detroit Street Trust | 3,11% | 1.841 NS | 30 Aprile 2026 | N-PORT |
| IYK · iShares Trust | 2,76% | 121.004 SH | 08 Agosto 2026 | Giornaliero |
| FXG · First Trust Exchange-Traded AlphaDE… | 2,40% | 19.060 NS | 30 Aprile 2026 | N-PORT |
| PAWZ · ProShares Trust | 2,36% | 2.847 NS | 31 Maggio 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 2,34% | 1.750 NS | 31 Maggio 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,26% | 12.908 SH | 08 Agosto 2026 | Giornaliero |
| MEDI · Harbor ETF Trust | 2,16% | 1.935 NS | 30 Aprile 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,91% | 186 NS | 30 Aprile 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,83% | 568.607 SH | 08 Agosto 2026 | Giornaliero |
| SWP · Manager Directed Portfolios | 1,75% | 10.059 NS | 31 Maggio 2026 | N-PORT |
| IWP · iShares Trust | 1,73% | 1.079.322 SH | 08 Agosto 2026 | Giornaliero |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 42.128 SH | 08 Agosto 2026 | Giornaliero |
| QIDX · Spinnaker ETF Series | 1,66% | 2.065 NS | 30 Aprile 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1,56% | 228 NS | 30 Aprile 2026 | N-PORT |
| USMV · iShares Trust | 1,29% | 958.985 SH | 08 Agosto 2026 | Giornaliero |
| ESMV · iShares Trust | 1,27% | 308 SH | 08 Agosto 2026 | Giornaliero |
| UPSD · ETF Series Solutions | 1,21% | 3.966 NS | 30 Aprile 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,17% | 7.354 NS | 30 Aprile 2026 | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1,17% | 1.161 NS | 30 Aprile 2026 | N-PORT |
| ACWV · iShares, Inc. | 1,17% | 120.628 SH | 08 Agosto 2026 | Giornaliero |
| FMAG · FIDELITY COVINGTON TRUST | 1,10% | 9.066 NS | 30 Aprile 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1,10% | 73.945 NS | 30 Aprile 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1,03% | 608.442 NS | 30 Aprile 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,02% | 1.555 NS | 30 Aprile 2026 | N-PORT |
| GROZ · Zacks Trust | 0,93% | 3.136 NS | 31 Maggio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,92% | 84.961 NS | 30 Aprile 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,90% | 1.187.313 SH | 08 Agosto 2026 | Giornaliero |
| CURE · Direxion Shares ETF Trust | 0,86% | 3.879 NS | 30 Aprile 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,85% | 45.117 SH | 08 Agosto 2026 | Giornaliero |
| IMCG · iShares Trust | 0,84% | 105.034 SH | 08 Agosto 2026 | Giornaliero |
| IXJ · iShares Trust | 0,80% | 102.068 SH | 08 Agosto 2026 | Giornaliero |
| ALTL · Pacer Funds Trust | 0,79% | 2.471 NS | 30 Aprile 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,79% | 6.030 NS | 30 Aprile 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,77% | 555.571 SH | 08 Agosto 2026 | Giornaliero |
| PALC · Pacer Funds Trust | 0,76% | 5.696 NS | 30 Aprile 2026 | N-PORT |
| RXL · ProShares Trust | 0,76% | 2.029 NS | 31 Maggio 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,75% | 285 NS | 31 Maggio 2026 | N-PORT |
| ROE · EA Series Trust | 0,73% | 7.012 NS | 29 Maggio 2026 | N-PORT |
| TAX · EA Series Trust | 0,72% | 680 NS | 29 Maggio 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,68% | 342 NS | 30 Aprile 2026 | N-PORT |
| DUHP · Dimensional ETF Trust | 0,68% | 249.048 NS | 30 Aprile 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,66% | 3.314 NS | 31 Maggio 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,63% | 18.623 SH | 08 Agosto 2026 | Giornaliero |
| VO · VANGUARD INDEX FUNDS | 0,50% | 4.005.623 SH | 08 Agosto 2026 | Giornaliero |
| QARP · DBX ETF Trust | 0,49% | 1.374 NS | 29 Maggio 2026 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0,47% | 2.120 NS | 31 Maggio 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,44% | 77.004 NS | 30 Aprile 2026 | N-PORT |
| IWR · iShares Trust | 0,43% | 760.297 SH | 08 Agosto 2026 | Giornaliero |
| IMCB · iShares Trust | 0,43% | 22.227 SH | 08 Agosto 2026 | Giornaliero |
| JSTC · Tidal Trust I | 0,40% | 4.993 NS | 31 Maggio 2026 | N-PORT |